article thumbnail

What the latest DEA Proposed Rule Means for Telemedicine Prescribing of Controlled Substances

Nixon Gwilt Law

If this data isn’t available, the practitioner must limit the prescription to a 7-day supply; Keeps detailed records regarding prescriptions written based on telemedicine encounters. Records can be kept in digital or paper form, and the proposed rule includes specific data points (e.g.,

article thumbnail

The importance of your product website

World of DTC Marketing

in 2008 to 38.5% SUMMARY: Among US adults who looked for health information and used the internet for their most recent search, the percentage who reported accessing health information without frustration was stable during the study period (from 37.2%

Pharma 180
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DTC for small, older, patient populations

World of DTC Marketing

While these numbers may pale in comparison with the 18-29 (86%) and 30-49 (61%) groups, it should be noted that as of November 2008 (a short time ago) only 16% of the 50-64-year-old group and 4% of the 65+ group were using Facebook. This represents 31% of all seniors in the US.

Patients 155
article thumbnail

Pharmacy Innovation Series: the DEA Steps into Telepharmacy Regulation

Nixon Gwilt Law

Examples of services that pharmacists may provide via telepharmacy include dispensing and distributing prescription medications, prescription verification, medication review, patient counseling, medication management, and drug therapy monitoring.

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

In 2008, the startup launched its first API to make and receive phone calls entirely in the cloud. Widespread adoption of these protocols allows every stakeholder in the environment to expect a well-defined behaviour when interfacing digitally with one another. The power of the open-protocol approach has been realised across many industries.

article thumbnail

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

pharmaphorum

Things became litigious in 2017, when a Delaware court found that Teva’s label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK’s RE40,000 patent, which was reissued by the Patent and Trademark Office (PTO) in 2008.

article thumbnail

GAMP 5 update: computerized system expectations for pharma manufacturers

European Pharmaceutical Review

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.”